Holland et. al. advocate for urgent implementation and rapid evidence generation for safer drug supply initiatives, especially in areas where drug deaths are escalating due to an unregulated drug supply.
On the occasion of the anniversary of WHO’s declaration of the pandemic, join us for a discussion on its impact on civil society advocacy, experiences of adaptation, recommendations and ways forward.
Wisse et al. argue that adaptations in the drug response in relation to COVID-19 should pave the way for positive and sustainable change in the health and criminal justice systems.
This last webinar will focus on drug policy and drug policy reform, especially in light of the failed and harmful "War on Drugs". It will explore the need to have a human rights based approach to drug policy that is done with meaningful involvement of people who use drugs.
This third webinar is aimed at discussing harm reduction services for non-injecting drug users and particularly people who use stimulant drugs in the time of COVID-19.
The AIDS and Rights Alliance for Southern Africa (ARASA) is inviting applications for the 2017 online training course on the rights of people who use drugs (PWUD), harm reduction, and drug policy reform.